Hildreth SW - Search Results

1

Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children.

Hall CB, Walsh EE, Schnabel KC, Long CE, McConnochie KM, Hildreth SW, Anderson LJ. Hall CB, et al. Among authors: hildreth sw. J Infect Dis. 1990 Dec;162(6):1283-90. doi: 10.1093/infdis/162.6.1283. J Infect Dis. 1990. PMID: 2230258

2

Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins.

Walsh EE, Hall CB, Schlesinger JJ, Brandriss MW, Hildreth S, Paradiso P. Walsh EE, et al. J Gen Virol. 1989 Nov;70 ( Pt 11):2953-61. doi: 10.1099/0022-1317-70-11-2953. J Gen Virol. 1989. PMID: 2479715

3

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.

Hall CB, McBride JT, Walsh EE, Bell DM, Gala CL, Hildreth S, Ten Eyck LG, Hall WJ. Hall CB, et al. N Engl J Med. 1983 Jun 16;308(24):1443-7. doi: 10.1056/NEJM198306163082403. N Engl J Med. 1983. PMID: 6343860 Clinical Trial.

4

The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection.

Gala CL, Hall CB, Schnabel KC, Pincus PH, Blossom P, Hildreth SW, Betts RF, Douglas RG Jr. Gala CL, et al. Among authors: hildreth sw. JAMA. 1986 Nov 21;256(19):2706-8. JAMA. 1986. PMID: 3773177

5

Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease.

Hall CB, McBride JT, Gala CL, Hildreth SW, Schnabel KC. Hall CB, et al. Among authors: hildreth sw. JAMA. 1985 Dec 6;254(21):3047-51. JAMA. 1985. PMID: 3903239 Clinical Trial.

6

Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old.

Tristram DA, Welliver RC, Mohar CK, Hogerman DA, Hildreth SW, Paradiso P. Tristram DA, et al. Among authors: hildreth sw. J Infect Dis. 1993 Jan;167(1):191-5. doi: 10.1093/infdis/167.1.191. J Infect Dis. 1993. PMID: 8418166 Clinical Trial.

7

Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine.

Welliver RC, Tristram DA, Batt K, Sun M, Hogerman D, Hildreth S. Welliver RC, et al. J Infect Dis. 1994 Aug;170(2):425-8. doi: 10.1093/infdis/170.2.425. J Infect Dis. 1994. PMID: 8035030 Clinical Trial.

8

Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old.

Paradiso PR, Hildreth SW, Hogerman DA, Speelman DJ, Lewin EB, Oren J, Smith DH. Paradiso PR, et al. Among authors: hildreth sw. Pediatr Infect Dis J. 1994 Sep;13(9):792-8. doi: 10.1097/00006454-199409000-00008. Pediatr Infect Dis J. 1994. PMID: 7808848 Clinical Trial.

9

Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunization.

Hildreth SW, Baggs RR, Brownstein DG, Castleman WL, Paradiso PR. Hildreth SW, et al. Vaccine. 1993;11(6):615-8. doi: 10.1016/0264-410x(93)90304-g. Vaccine. 1993. PMID: 8322482

10

Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection.

Welliver RC, Sun M, Hildreth SW, Arumugham R, Ogra PL. Welliver RC, et al. Among authors: hildreth sw. J Clin Microbiol. 1989 Feb;27(2):295-9. doi: 10.1128/jcm.27.2.295-299.1989. J Clin Microbiol. 1989. PMID: 2915022 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters